Listen Now
Topics Covered
- Overview of Triple Negative Breast Cancer, in the Context of COVID-19 & Its Variants
- New Research on TNBC Presented at SABCS
- Triple Negative Breast Cancer-Specific Treatment Updates
- Updates on Clinical Trials in Advancing Treatment Choices
- The Increasing Role of Diagnostic Testing, Biomarkers & Genetic Testing in Informing Treatment Options
- Investigational New Therapies in Clinical Trials
- New Developments in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
- Communicating with the Health Care Team with Telehealth/Telemedicine Appointments
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, List of Questions, Adherence, Follow-Up Care & Discussion of OpenNotes
- Questions for Our Panel of Experts
Our Panel of Experts

Virginia Kaklamani, MD, DSc
Professor of Medicine, Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment, A.B. Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program, UT Health San Antonio, MD Anderson Cancer Center

Kamel Abou Hussein, MD
Assistant Professor of Medicine, Cooper Medical School of Rowan University Adjunct Assistant Professor Department of Breast Medical Oncology, MD Anderson Cancer Center Co-Director of the Janet Knowles Breast Cancer Program Director of Breast Cancer Clinical Trials at MD Anderson Cancer Center at Cooper

Arlene Brothers
Director of Administration, Triple Negative Breast Cancer Foundation®

Lauren Chatalian, MSW
Director of Advocacy, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on December 20, 2022.